Table 2: Post-operative, pathological and mid-long term oncological outcomes.

Variable

N=85 (%) mean±SD

Median (range)

30 day/in hospital mortality

2 (2.3%)

 

90-day/in-hospital mortality

3 (3.5%)

 

Post-operative complications

35 (41.2%)

 

Clavien-Dindo classification

2

3a

3b

4a

5

 

 

23 (27%)

4 (4.7%)

3 (3.5%)

2 (2.4%)

3 (3.5%)

 

Hospital stay

11.28±19.7

8 (3-180)

ICU stay

3.8±19.7

1 (1-160)

Pathological tumor diameter (mm)

34±20.8

 

pT

0

1a

1b

1c

2a

2b

3

4

 

11 (12.9%)

7 (8.2%)

11 (12.9%)

9 (10.6%)

17 (20%)

11 (12.9%)

11 (12.9%)

8 (9.4%)

 

pN

0

1

2

 

44 (51.8%)

14 (16.4%)

27 (31.8%)

 

pN subclassification

N1a

N1b

N2a1

N2a2

N2b

 

11 (12.9%)

3 (3.5%)

16 (18.8%)

3 (3.5%)

8 (9.4%)

 

Mediastinal involvement

Single

Two station

Multiple station

 

 

13 (48.1%)

9 (33.3%)

5 (18.6%)

 

pStage

0

IA

IB

IIA

IIB

IIIA

IIIB

 

7 (8.2%)

14 (16.5%)

5 (5.9%)

5 (5.9%)

19 (22.4%)

30 (35.3%)

5 (5.9%)

 

SD: Standard Deviation; ICU: Intensive Care Unit.